Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Open Access

Ten-Year Real-World Outcomes and Clinicopathologic Predictors of Recurrence in Adult Granulosa Cell Tumors: A Turkish Single-Center Experience

View Full Paper
Ask AI
Bookmark
Share

Authors

AGAslı GeçgelEge UniversityOÖOğuzcan ÖzkanUniversity Medical CenterPPPınar PekerEge University

Discussion

Loading...

Member takes

Overview

Retrospective cohort study shows increased recurrence in advanced FIGO stage granulosa cell tumors, suggesting tailored follow-up plans.

Key Points

  • Recurrence occurred in 23.6% of patients, indicating a significant challenge in managing advanced-stage granulosa cell tumors.
  • The median disease-free survival was 92.3 months, while overall survival reached 113.7 months in the cohort of 55 patients.
  • Retrospective cohort study evaluated survival outcomes with Kaplan–Meier analysis, supporting the need for careful monitoring.
  • Identifying advanced-stage disease as an independent predictor highlights the importance of personalized patient care strategies.

Cite This Study

Geçgel et al. (2025) studied this question.

synapsesocial.com/papers/68c1c31b54b1d3bfb60f09c9https://doi.org/10.20944/preprints202508.0598.v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A 30-year study of 355 cases with adult-type ovarian granulosa cell tumors in a tertiary center: Clinical features and factors predicting recurrence2025
  2. 216P Granulosa cell tumor of the ovary: 10-year follow-up data of 56 patients2024
  3. 3Recurrence of Adult Granulosa Cell Tumors: The Factors Affecting Secondary Recurrence and Survival After Recurrence2026
  4. 4The experıance of tertıary center for adult granulosa cell tumor: whıch factors predıct survival?2024 · 5 citations
  5. 5516 A Dutch prospective cohort study of 190 patients with adult granulosa cell tumour2024